Table 4.
Variable* | Hazard Ratio for Death from Soft Tissue Sarcoma (95% Confidence Interval) |
---|---|
Primary Site** | |
Extremity | 1.00 (referent) |
Trunk | 5.98 (1.01 – 35.48) |
Other¶ | 19.80 (4.26 – 92.10) |
Visceral† | 16.09 (2.86 – 90.62) |
Retroperitoneal | 59.10 (13.22 – 264.32) |
Primary Tumor Size | |
≤ 5 cm | 1.00 (referent) |
> 5 cm ≤ 10 cm | 6.78 (1.98 – 23.14) |
> 10 cm | 10.23 (3.06 – 34.27) |
Histology | |
Other¶¶ | 1.00 (referent) |
Malignant Fibrous | 1.05 (0.32 – 3.48) |
Histiocytoma (MFH) | |
Leiomyosarcoma | 2.14 (0.73 – 6.27) |
Liposarcoma | 1.87 (1.08 – 3.25) |
Margin Status | |
R0 | 1.00 (referent) |
R1 | 2.26 (1.40 – 3.68) |
R2 | 5.86 (3.42 – 10.04) |
Variables significant at the 0.10 level on univariate analysis were included in the multivariate model. Gender, depth, and age were not statistically significant variables on multivariate analysis. Treatment-related variables were not included in the multivariate model since their association with the outcome of interest could not be assumed to be independent.
Although there were significant differences in DOLR by primary tumor site, multivariate analysis demonstrated liposarcoma histology to be a more reliable predictor of DOLR than site, likely because site and histology are tightly linked covariables.
Includes thoracic, head and neck, and skin.
Includes gastrointestinal, gynecologic, and genitourinary.
Includes all histologies except MFH, leiomyosarcoma, and liposarcoma.